摘要
目的研究静脉留置针在恶性肿瘤患者化疗中的临床应用效果。方法将174例首次化疗的恶性肿瘤患者,根据本人意愿随机分成实验组A 88例,采用静脉留置针输液化疗;对照组B 86例,采用常规头皮针输液化疗。结果①两组静脉炎和渗漏的发生率没有统计学差异(P>0.05)。②静脉炎的发生与不同化疗药物的理化性质直接相关(P<0.05);③静脉炎与静脉化疗时间呈正相关,时间越长,发生率越高,而两组间差异无统计学意义。结论静脉留置针同样适用于恶性肿瘤患者的静脉化疗,尤其对条件限制无法做PICC和深静脉穿刺者是不错的选择。
Aim To sdudy the clinical effects of indwelling needle in vein on malignant tumor patient＇s chemotherapy. Methods According to their own wishes, 174 cases of malignant tumor patients who had chemotherapy for the first time were assigned to the experimental group A in which 88 cases adopted indwelling needle in vein for intravenous transfusion and the control group B in which 86 cases adopted scalp acupuncture for intravenous transfusion. Results First, there are no differences in phlebitis and leak between two groups P 〉 0. 05. Second,the incident of phlebitis directly related to physical and chemical properties of different chemotherapy drugs P 〈 0. 05. Third, phlebitis correlated positively with the time of intravenous chemotherapy. The longer the time, the higher the incidence. There was no statistical significance in differences between the two groups. Conclusion Indwelling needle in vein also applies to intravenous chemotherapy of cancer patients. In particular, for the ones who are not suitable for PICC implementation and deep venous puncture, indwelling needle in vein is a good choice.
出处
《安徽医药》
CAS
2008年第1期73-74,共2页
Anhui Medical and Pharmaceutical Journal
关键词
静脉留置针
恶性肿瘤
化疗
indwelling needle in vein
malignant tumor
chemotherapy
